Scrip Stock Tracker: August 2009
This article was originally published in Scrip
After a busy second-quarter reporting month in July, August tends to fall a little flat as the mass exodus for annual vacations begins. Fund managers still keep in touch with trading, but the markets can be thin.
You may also be interested in...
The value of rare disease research must not be overlooked as the drive to diagnose and contain coronavirus mounts.
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
The consensus among investors is that medtech has been the best-performing part of health care for the past three to four years, and investment levels remain good. Seemingly all-encompassing of late has been companies’ preoccupation with digital strategies, but there is a lot more to this unique industry than just digital.